Natus Medical Incorporated (NTUS) is a Biotechnology: Electromedical & Electrotherapeutic Apparatus company listed on NASDAQ. There were no new wire items for NTUS in the last 30 days. The most recent was published Sep 18, 2023.

Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and services used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; balance assessment systems to evaluate patients with balance disorders. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was founded in 1987 and is headquartered in Pleasanton, California.

Latest news

25 items

NTUS FAQ

6 questions
  • What does Natus Medical Incorporated do?
    Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and services used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and...
  • What is the latest news on NTUS?
    Quantisnow has not tracked any new filings, ratings or press releases for NTUS in the last 30 days. The most recent wire item was published on September 18, 2023.
  • Where does NTUS stock trade?
    Natus Medical Incorporated (NTUS) is listed on NASDAQ.
  • What sector and industry is NTUS in?
    Natus Medical Incorporated operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.
  • What companies are similar to NTUS?
    Notable peers in the same industry include INMD (InMode Ltd.), AXGN (Axogen Inc.), TMDX (TransMedics Group Inc.), MDT (Medtronic plc.), LIVN (LivaNova PLC). Compare NTUS side-by-side with any of them on Quantisnow.
  • How can I track NTUS on Quantisnow?
    Quantisnow aggregates Natus Medical Incorporated's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NTUS to receive live email and push alerts on every new disclosure.